skip to content
Thank you for visiting First Coast Service Options' Medicare provider website. This website is intended exclusively for Medicare providers and health care industry professionals to find the latest Medicare news and information affecting the provider community.
To enable us to present you with customized content that focuses on your area of interest, please select your preferences below:
Select which best describes you:
Select your location:
Select your line of business:
This website provides information and news about the Medicare program for health care professionals only. All communication and issues regarding your Medicare benefits are handled directly by Medicare and not through this website. Information for Medicare beneficiaries is only available on the medicare.gov website.
En Español
Text Size:
Send a link to this page
[Multiple email adresses must be separated by a semicolon.]

Retired LCDs

Modified: 8/16/2017
LCD L33807 Caspofungin acetate (Cancidas), retired, Part B
Modified: 8/17/2017
LCD L33809 Chelation Therapy, Part B retired
Modified: 8/16/2017
LCD L33987 Computerized Dynamic Posturography, retired, Part A/B
Modified: 11/27/2017
LCD L33811 Corticotropin, Part B retired
Modified: 11/6/2017
LCD L34042 Creatine Kinase (CK), (CPK), Part AB retired
Modified: 11/6/2017
LCD L33819 External Ocular Photography, Part B retired
Modified: 10/23/2017
LCD L34000 Ganciclovir and Cidofovir, retired Part AB
Modified: 8/16/2017
LCD L33913 Interferon, retired, Part B
Modified: 8/17/2017
LCD L33379 Intraoperative Neurophysiology Monitoring, retired Part AB
Modified: 10/23/2017
LCD L33504Intravitreal Bevacizumab (Avastin®), retired Part AB
Modified: 8/17/2017
LCD L33381 Low Density Lipoprotein (LDL) Apheresis, Part AB - retired
Modified: 8/16/2017
LCD L33919 Macugen (pegaptanib sodium injection), retired, Part B
Modified: 11/6/2017
LCD L 33920 Mastoidectomy Cavity Debridement, Part B retired
Modified: 11/6/2017
LCD L34015 Mitomycin (Mutamycin®, Mitomycin-C), Part AB - retired
Modified: 8/16/2017
LCD L33705 Ocular Photodynamic Therapy (OPT) with Verteporfin, retired
Modified: 8/16/2017
LCD L33928 Osteogenic Stimulation, retired, Part B
Modified: 8/16/2017
LCD L33708 Plerixafor (Mozobil®), retired, Part A/B
Modified: 8/16/2017
LCD L33596 Qutenza® (capsaicin) 8% patch, retired, Part A/B
Modified: 8/16/2017
LCD L33407 Ranibizumab (Lucentis®), retired, Part A/B
Modified: 11/6/2017
LCD L34019 Rho (D) Immune Globulin Intravenous , Part AB - retired
Modified: 10/23/2017
LCD L34020 Sargramostim (GM-CSF, Leukine®), retired, Part A/B
Modified: 10/23/2017
LCD L34001 Vinorelbine Tartrate (Navelbine®), retired Part AB
Modified: 12/7/2017
LCD L33566 Wound Debridement Services, Part AB - retired
First Coast Service Options (First Coast) strives to ensure that the information available on our provider website is accurate, detailed, and current. Therefore, this is a dynamic site and its content changes daily. It is best to access the site to ensure you have the most current information rather than printing articles or forms that may become obsolete without notice.